^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HLX55

    i
    Other names: HLX55, HLX-55, KTN0216, KTN 0216, humanized IgG2 monoclonal antibody
    Associations
    News

    Trials

    Company:
    Fosun Pharma, Shanghai Henlius Biotech
    Drug class:
    c-MET inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status (NCT04169178)
    Phase 1
    Henlix, Inc
    Recruiting
    Last update posted :
    05/01/2020
    Initiation :
    03/03/2020
    Primary completion :
    12/01/2022
    Completion :
    12/01/2022
    KRAS • MET
    |
    MET amplification • MET exon 14 mutation • MET overexpression • MET mutation
    |
    HLX55